Cite

HARVARD Citation

    Mylonakis, E. et al. (n.d.). LB4. Casirivimab and Imdevimab for Treatment of Hospitalized Patients With COVID-19 Receiving Low Flow or No Supplemental Oxygen. Open forum infectious diseases. pp. S809-S810. [Online]. 
  
Back to record